Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 14,138 | 20,761 | 10,487 | 5,315 | 19,546 |
| Cost of Goods | 13,611 | 15,209 | 8,975 | 4,727 | 15,031 |
| Gross Profit | 527 | 5,552 | 1,512 | 588 | 4,514 |
| Operating Expenses | 1,714 | 2,042 | 0 | -1,165 | 2,005 |
| Operating Income | -1,187 | 3,510 | 1,512 | 1,753 | 2,510 |
| Interest Expense | 192 | 230 | 128 | N/A | N/A |
| Other Income | -9 | 3 | -2,472 | -9,694 | -671 |
| Pre-tax Income | -1,388 | 3,283 | -1,087 | -7,941 | 1,839 |
| Income Tax | -388 | 1,064 | -318 | 514 | 616 |
| Net Income Continuous | -1,000 | 2,219 | -770 | -8,455 | 1,223 |
| Net Income | $-1,000 | $2,219 | $-770 | $-8,455 | $1,223 |
| EPS Basic Total Ops | -0.04 | 0.09 | -0.03 | -0.34 | 0.05 |
| EPS Basic Continuous Ops | -0.04 | 0.09 | -0.03 | -0.34 | 0.05 |
| EPS Diluted Total Ops | -0.04 | 0.09 | -0.03 | -0.34 | 0.05 |
| EPS Diluted Continuous Ops | -0.04 | 0.09 | -0.03 | -0.34 | 0.05 |
| EBITDA(a) | $790 | $5,645 | $71 | $-9,983 | $4,514 |